Skip to content

Saliva as a diagnostic specimen for testing respiratory virus in children

Saliva as a diagnostic specimen for testing respiratory virus in children

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR1900028436
Enrollment
Unknown
Registered
2019-12-21
Start date
2020-01-03
Completion date
Unknown
Last updated
2020-01-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

infection of respiratory virus

Interventions

Gold Standard:nasopharyngeal swab
Index test:saliva

Sponsors

The University of Hong Kong-Shenzhen Hospital
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. admission to fever clinic of department of Accident and Emergency of our hospital 2. aged<18 years old 3. at least 1 of the following focal signs or symptoms: cough, rhinitis (rhinorrhoea or nasal obstruction), pharyngitis (sore throat), shortness of breath, wheezing, chest pain, and auscultation abnormalities 4. at least 1 of the following systemic signs or symptoms: fever, perspiration, headache, myalgia, and feeling generally unwell 5. less than one day of hospital admission at the time of patient recruitment 6. a duration of illness less than or equal to 7 days 7. willingness to sign written informed consent 8. willingness to provide nasopharyngeal swab specimen

Exclusion criteria

Exclusion criteria: 1. contraindication for the collection of nasopharyngeal swab(such as bleeding tendency) 2. inability to provide saliva specimen 3. respiratory specimens tested for respiratory viruses within the past 7 days before hospital admission

Design outcomes

Primary

MeasureTime frame
concordance rate;

Secondary

MeasureTime frame
Ct value analysis;

Countries

China

Contacts

Public ContactKelvin Kai Wang TO

the University of Hong Kong-Shenzhen Hospital

kelvinto@hku.hk+86 0755-86913333

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026